Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in Scand J Rheumatol

Retrieve available abstracts of 131 articles:
HTML format



Single Articles


    July 2021
  1. VUOLTEENAHO K, Tuure L, Nieminen R, Laasonen L, et al
    Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
    Scand J Rheumatol. 2021 Jul 15:1-6. doi: 10.1080/03009742.2021.1929456.
    PubMed     Abstract available


    June 2021
  2. PEDERSEN JK, Andersen K, Svendsen AJ, Horslev-Petersen K, et al
    No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort.
    Scand J Rheumatol. 2021 Jun 29:1-7. doi: 10.1080/03009742.2021.1923148.
    PubMed     Abstract available


  3. MCCOY SS, Greenlee RT, VanWormer JJ, Schletzbaum M, et al
    Smoking associated with reduced odds of Sjogren's syndrome among rheumatoid arthritis patients.
    Scand J Rheumatol. 2021 Jun 25:1-5. doi: 10.1080/03009742.2021.1925584.
    PubMed     Abstract available


  4. VERSTEEG GA, Steunebrink L, Vonkeman HE, Ten Klooster PM, et al
    Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission.
    Scand J Rheumatol. 2021 Jun 21:1-10. doi: 10.1080/03009742.2021.1917161.
    PubMed     Abstract available


  5. TAN YK, Teo P, Saffari SE, Xin X, et al
    A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2021 Jun 10:1-9. doi: 10.1080/03009742.2021.1901416.
    PubMed     Abstract available


    May 2021
  6. SCHAFER C
    Early description of polyarthritis possibly representing rheumatoid arthritis given by a patient, as recorded in a textbook on gout from 1788.
    Scand J Rheumatol. 2021 May 5:1-2. doi: 10.1080/03009742.2021.1894824.
    PubMed    


    April 2021
  7. GAO J, Xin L, Guo Q, Xu K, et al
    Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2021 Apr 14:1-5. doi: 10.1080/03009742.2021.1882557.
    PubMed     Abstract available


    March 2021
  8. BRUNET SC, Tse JJ, Kuczynski MT, Engelke K, et al
    Heterogenous bone response to biologic DMARD therapies in rheumatoid arthritis patients and their relationship to functional indices.
    Scand J Rheumatol. 2021 Mar 29:1-10. doi: 10.1080/03009742.2020.1869303.
    PubMed     Abstract available


  9. KNUDSEN SS, Thomsen A, Deleuran BW, Bech BH, et al
    Maternal rheumatoid arthritis during pregnancy and neurodevelopmental disorders in offspring: a systematic review.
    Scand J Rheumatol. 2021 Mar 23:1-9. doi: 10.1080/03009742.2021.1882559.
    PubMed     Abstract available


  10. AGCA R, Heslinga M, Raterman HG, Simsek S, et al
    Coexistent subclinical hypothyroidism is associated with an increased risk of new cardiovascular events in rheumatoid arthritis: an explorative study.
    Scand J Rheumatol. 2021 Mar 23:1-4. doi: 10.1080/03009742.2021.1891279.
    PubMed     Abstract available


  11. TER WEE MM, Raterman HG, van Schoor NM, Deeg D, et al
    Accuracy of an algorithm to identify rheumatoid arthritis in the Longitudinal Ageing Study Amsterdam population: a validation study.
    Scand J Rheumatol. 2021 Mar 15:1-5. doi: 10.1080/03009742.2020.1852442.
    PubMed     Abstract available


  12. ENDO Y, Kawashiri SY, Nishino A, Okamoto M, et al
    Discrepancy between clinical and ultrasound remissions in rheumatoid arthritis: a multicentre ultrasound cohort study in Japan.
    Scand J Rheumatol. 2021 Mar 15:1-6. doi: 10.1080/03009742.2021.1876914.
    PubMed     Abstract available


  13. BERGSTROM M, Dahlstrom O, Thyberg I, Bjork M, et al
    The role of support from significant others in the association between disease-related factors and sickness absence in early rheumatoid arthritis: a longitudinal study.
    Scand J Rheumatol. 2021 Mar 6:1-8. doi: 10.1080/03009742.2020.1870712.
    PubMed     Abstract available


  14. RAJAMOHAN A, Heit B, Cairns E, Barra L, et al
    Citrullinated and homocitrullinated low- density lipoprotein in rheumatoid arthritis.
    Scand J Rheumatol. 2021 Mar 6:1-8. doi: 10.1080/03009742.2020.1867237.
    PubMed     Abstract available


  15. D'AMICO ME, Silvagni E, Carrara G, Zanetti A, et al
    Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases.
    Scand J Rheumatol. 2021 Mar 4:1-10. doi: 10.1080/03009742.2020.1855365.
    PubMed     Abstract available


    February 2021
  16. SCHELIN M, Westerlind H, Lindqvist J, Englid E, et al
    Widespread non-joint pain in early rheumatoid arthritis.
    Scand J Rheumatol. 2021 Feb 25:1-9. doi: 10.1080/03009742.2020.1846778.
    PubMed     Abstract available


  17. PRIMDAHL J, Esbensen BA, Pedersen AK, Bech B, et al
    Validation of the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaires (BRAFs).
    Scand J Rheumatol. 2021 Feb 19:1-9. doi: 10.1080/03009742.2020.1869301.
    PubMed     Abstract available


  18. ZIEGELASCH M, Forslind K
    Simplified Larsen erosion score (SLES) for estimating joint damage in early rheumatoid arthritis in clinical practice.
    Scand J Rheumatol. 2021 Feb 16:1-2. doi: 10.1080/03009742.2020.1846780.
    PubMed    


  19. MA JD, Chen CT, Lin JZ, Li QH, et al
    Muscle wasting, a neglected complication associated with physical dysfunction in elderly patients with rheumatoid arthritis: a cross-sectional observational study.
    Scand J Rheumatol. 2021 Feb 8:1-10. doi: 10.1080/03009742.2020.1842902.
    PubMed     Abstract available


    January 2021
  20. HAMMER HB, Hansen I, Jarvinen P, Leirisalo-Repo M, et al
    Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis.
    Scand J Rheumatol. 2021 Jan 19:1-9. doi: 10.1080/03009742.2020.1845394.
    PubMed     Abstract available


  21. HEDENSTIERNA L, Opava CH, Askling J, Jiang X, et al
    Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study.
    Scand J Rheumatol. 2021 Jan 12:1-5. doi: 10.1080/03009742.2020.1813325.
    PubMed     Abstract available


    December 2020
  22. JONSSON AB, Johansen CV, Rolving N, Pfeiffer-Jensen M, et al
    Feasibility and estimated efficacy of blood flow restricted training in female patients with rheumatoid arthritis: a randomized controlled pilot study.
    Scand J Rheumatol. 2020 Dec 10:1-9. doi: 10.1080/03009742.2020.1829701.
    PubMed     Abstract available


    November 2020
  23. XU X, Estekizadeh A, Davoudi B, Varani S, et al
    Detection of human cytomegalovirus in synovial neutrophils obtained from patients with rheumatoid arthritis.
    Scand J Rheumatol. 2020 Nov 27:1-6. doi: 10.1080/03009742.2020.1825798.
    PubMed     Abstract available


  24. KOIVUNIEMI R, Kuuliala A, Kivisto S, Holmstrom M, et al
    Induction of remission in female rheumatoid arthritis patients is associated with stabilization of myocardial abnormalities: a prospective cardiac magnetic resonance follow-up study.
    Scand J Rheumatol. 2020 Nov 27:1-9. doi: 10.1080/03009742.2020.1818819.
    PubMed     Abstract available


    October 2020
  25. KAWASHIRI SY, Nishino A, Shimizu T, Takatani A, et al
    Fluorescence optical imaging in patients with active rheumatoid arthritis: a comparison with ultrasound and an association with biomarkers.
    Scand J Rheumatol. 2020 Oct 21:1-9. doi: 10.1080/03009742.2020.1794028.
    PubMed     Abstract available


  26. DREWES AM, Brock C, Rasmussen SE, Moller HJ, et al
    Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study.
    Scand J Rheumatol. 2020 Oct 13:1-8. doi: 10.1080/03009742.2020.1764617.
    PubMed     Abstract available


  27. SIDIRAS P, Spruyt D, Gangji V, Imbault V, et al
    Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
    Scand J Rheumatol. 2020 Oct 7:1-6. doi: 10.1080/03009742.2020.1798500.
    PubMed     Abstract available


    September 2020
  28. ITAMIYA T, Komai T, Tsuchida Y, Shoda H, et al
    Varicella zoster virus myelitis in a patient with rheumatoid arthritis treated by tofacitinib.
    Scand J Rheumatol. 2020 Sep 17:1-3. doi: 10.1080/03009742.2020.1800082.
    PubMed    


  29. ENDO Y, Koga T, Kawashiri SY, Morimoto S, et al
    Significance of anti-Ro/SSA antibodies in the response and retention of abatacept in patients with rheumatoid arthritis: a multicentre cohort study.
    Scand J Rheumatol. 2020 Sep 3:1-5. doi: 10.1080/03009742.2020.1772361.
    PubMed     Abstract available


  30. SHIMIZU H, Nishioka H
    Adult-onset Still's disease accompanied by erythema multiforme presenting as an atypical rash.
    Scand J Rheumatol. 2020;49:422-423.
    PubMed    


    August 2020
  31. ZIEGELASCH M, Boman A, Martinsson K, Thyberg I, et al
    Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011.
    Scand J Rheumatol. 2020 Aug 28:1-9. doi: 10.1080/03009742.2020.1771761.
    PubMed     Abstract available


  32. LEU AGELII M, Andersson M, Jones BL, Sjowall C, et al
    Disease activity trajectories in rheumatoid arthritis: a tool for prediction of outcome.
    Scand J Rheumatol. 2020 Aug 28:1-10. doi: 10.1080/03009742.2020.1774646.
    PubMed     Abstract available


  33. DURYEA J, Gravallese EM, Wortman JR, Xu C, et al
    Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.
    Scand J Rheumatol. 2020 Aug 6:1-4. doi: 10.1080/03009742.2020.1772362.
    PubMed     Abstract available


    July 2020
  34. BJORSENIUS I, Rantapaa-Dahlqvist S, Berglin E, Sodergren A, et al
    Extent of atherosclerosis after 11-year prospective follow-up in patients with early rheumatoid arthritis was affected by disease severity at diagnosis.
    Scand J Rheumatol. 2020 Jul 21:1-9. doi: 10.1080/03009742.2020.1767200.
    PubMed     Abstract available


  35. HUSBERG M, Bernfort L, Hallert E
    Presence of anti-citrullinated protein antibodies and costs and disease activity in early rheumatoid arthritis - a 3-year follow-up.
    Scand J Rheumatol. 2020 Jul 20:1-10. doi: 10.1080/03009742.2020.1750688.
    PubMed     Abstract available


  36. ZHANG Y, Peltonen M, Andersson-Assarsson JC, Svensson PA, et al
    Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity.
    Scand J Rheumatol. 2020 Jul 15:1-9. doi: 10.1080/03009742.2020.1753808.
    PubMed     Abstract available


  37. NYSTAD TW, Fenstad AM, Fevang BT
    Major differences in medical and surgical treatment of psoriatic arthritis and rheumatoid arthritis: a comparison of two historic cohorts.
    Scand J Rheumatol. 2020;49:267-270.
    PubMed     Abstract available


  38. HONDA M, Moriyama M, Kondo M, Kumakura S, et al
    Tofacitinib-induced remission in refractory adult-onset Still's disease complicated by macrophage activation syndrome.
    Scand J Rheumatol. 2020;49:336-338.
    PubMed    


    June 2020
  39. SVENSSON B, Forslind K, Andersson M
    Unacceptable pain in the BARFOT inception cohort of patients with rheumatoid arthritis: a long-term study.
    Scand J Rheumatol. 2020 Jun 4:1-8. doi: 10.1080/03009742.2020.1729404.
    PubMed     Abstract available


  40. WOUTERS F, Matthijssen X, Boeters DM, Ten Brinck RM, et al
    Do magnetic resonance imaging-detected erosions predict progression to rheumatoid arthritis in patients presenting with clinically suspect arthralgia? A longitudinal study.
    Scand J Rheumatol. 2020 Jun 2:1-7. doi: 10.1080/03009742.2020.1737221.
    PubMed     Abstract available


    May 2020
  41. EMERY P, Suh CH, Weinblatt ME, Smolen JS, et al
    Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.
    Scand J Rheumatol. 2020 May 29:1-10. doi: 10.1080/03009742.2020.1732458.
    PubMed     Abstract available


  42. MATSUOKA H, Kabata D, Taura A, Matsui T, et al
    Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.
    Scand J Rheumatol. 2020;49:253-255.
    PubMed    


  43. VASAITIS L, Nordmark G, Theander E, Backlin C, et al
    Population-based study of patients with primary Sjogren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences.
    Scand J Rheumatol. 2020;49:225-232.
    PubMed     Abstract available


  44. AYAR K, Tunc R, Pekel H, Esen HH, et al
    Prevalence of sicca symptoms and Sjogren's syndrome in coeliac patients and healthy controls.
    Scand J Rheumatol. 2020;49:233-238.
    PubMed     Abstract available


    April 2020
  45. RODRIGUEZ-MUGURUZA S, Combe B, Guillemin F, Fautrel B, et al
    Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort.
    Scand J Rheumatol. 2020 Apr 30:1-8. doi: 10.1080/03009742.2020.1726449.
    PubMed     Abstract available


  46. VINCI C, Infantino M, Raturi S, Tindell A, et al
    Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis.
    Scand J Rheumatol. 2020 Apr 21:1-11. doi: 10.1080/03009742.2020.1713395.
    PubMed     Abstract available


  47. BOZOVIC G, Larsson H, Wuttge DM, Hakansson M, et al
    Successful lung transplantation in a patient with rheumatoid arthritis suffering from obliterative bronchiolitis.
    Scand J Rheumatol. 2020 Apr 16:1-2. doi: 10.1080/03009742.2020.1727006.
    PubMed    


    March 2020
  48. NAFFAA ME, Rosenberg V, Watad A, Tiosano S, et al
    Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study.
    Scand J Rheumatol. 2020 Mar 25:1-8. doi: 10.1080/03009742.2019.1695928.
    PubMed     Abstract available


  49. BOER AC, Boeters DM, Niemantsverdriet E, van der Helm-van Mil A, et al
    Contribution of tenosynovitis of small joints to the symptom morning stiffness in patients presenting with undifferentiated and rheumatoid arthritis.
    Scand J Rheumatol. 2020 Mar 17:1-5. doi: 10.1080/03009742.2019.1696404.
    PubMed     Abstract available


  50. DAHMEN R, Konings-Pijnappels A, Kerkhof S, Verberne S, et al
    Higher body mass index is associated with lower foot health in patients with rheumatoid arthritis: baseline results of the Amsterdam-Foot cohort.
    Scand J Rheumatol. 2020 Mar 10:1-9. doi: 10.1080/03009742.2019.1663920.
    PubMed     Abstract available


  51. DAVIES K, Collins A, Charlton FG, Ng WF, et al
    Nodular localized primary cutaneous amyloidosis and primary Sjogren's syndrome.
    Scand J Rheumatol. 2020;49:159-160.
    PubMed    


    January 2020
  52. HEUS A, Arends S, Van Nimwegen JF, Stel AJ, et al
    Pulmonary involvement in primary Sjogren's syndrome, as measured by the ESSDAI.
    Scand J Rheumatol. 2020;49:38-46.
    PubMed     Abstract available


  53. ORNBJERG LM, Christensen KB, Tennant A, Hetland ML, et al
    Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias.
    Scand J Rheumatol. 2020;49:1-7.
    PubMed     Abstract available


  54. MINALI PA, Pimentel C, de Mello MT, Lima G, et al
    Effectiveness of resistance exercise in functional fitness in women with primary Sjogren's syndrome: randomized clinical trial.
    Scand J Rheumatol. 2020;49:47-56.
    PubMed     Abstract available


    November 2019
  55. HORNBERG K, Pomeroy J, Sandberg C, Sodergren A, et al
    Physical activity in rheumatoid arthritis: relationship to cardiovascular risk factors, subclinical atherosclerosis, and disease activity.
    Scand J Rheumatol. 2019 Nov 19:1-10. doi: 10.1080/03009742.2019.1657491.
    PubMed     Abstract available


    October 2019
  56. DAM TT, Okamura K, Nakajima T, Yonemoto Y, et al
    Axillary lymph-node metabolic activity assessment on (18)F-FDG-PET/CT in rheumatoid arthritis patients treated with biologic therapies.
    Scand J Rheumatol. 2019 Oct 3:1-9. doi: 10.1080/03009742.2019.1650106.
    PubMed     Abstract available


    September 2019
  57. SCHWANECK EC, Renner R, Junker L, Tony HP, et al
    T cells, natural killer cells, and gammadeltaT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy.
    Scand J Rheumatol. 2019 Sep 26:1-5. doi: 10.1080/03009742.2019.1634755.
    PubMed     Abstract available


  58. JONSSON MK, Kantyka T, Falkowski K, Aliko A, et al
    Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis.
    Scand J Rheumatol. 2019 Sep 23:1-9. doi: 10.1080/03009742.2019.1641216.
    PubMed     Abstract available


  59. AXELSEN MB, Boesen M, Bliddal H, Jacobsson L, et al
    Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis.
    Scand J Rheumatol. 2019 Sep 16:1-7. doi: 10.1080/03009742.2019.1639820.
    PubMed     Abstract available


  60. KANESHIRO K, Sakai Y, Suzuki K, Uchida K, et al
    Interleukin-6 and tumour necrosis factor-alpha cooperatively promote cell cycle regulators and proliferate rheumatoid arthritis fibroblast-like synovial cells.
    Scand J Rheumatol. 2019;48:353-361.
    PubMed     Abstract available


  61. MEYER MK, Andersen M, Ring T, Andersen GN, et al
    Personalized rheumatic medicine through dose reduction reduces the cost of biological treatment - a retrospective intervention analysis.
    Scand J Rheumatol. 2019;48:398-407.
    PubMed     Abstract available


  62. PETERSEN SK, Hansen I, Andreasen RA
    Low frequency of septic arthritis after arthrocentesis and intra-articular glucocorticoid injection.
    Scand J Rheumatol. 2019;48:393-397.
    PubMed     Abstract available


  63. PERTOVAARA M, Korpela M
    Fatigue correlates with signs of immunological activity and patient-reported outcomes in patients with primary Sjogren's syndrome.
    Scand J Rheumatol. 2019;48:418-419.
    PubMed    


    August 2019
  64. ENDO Y, Koga T, Kawashiri SY, Morimoto S, et al
    Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan.
    Scand J Rheumatol. 2019 Aug 12:1-5. doi: 10.1080/03009742.2019.1627411.
    PubMed     Abstract available


    July 2019
  65. NYHALL-WAHLIN BM, Ajeganova S, Petersson IF, Andersson M, et al
    Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study.
    Scand J Rheumatol. 2019 Jul 19:1-8. doi: 10.1080/03009742.2019.1611918.
    PubMed     Abstract available


  66. BEHRENS F, Koehm M, Schwaneck EC, Schmalzing M, et al
    Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.
    Scand J Rheumatol. 2019 Jul 16:1-8. doi: 10.1080/03009742.2019.1600717.
    PubMed     Abstract available


  67. FORSLIND K, Svensson B
    Repair of bone erosions in rheumatoid arthritis: a systematic literature review.
    Scand J Rheumatol. 2019 Jul 16:1-6. doi: 10.1080/03009742.2019.1606274.
    PubMed     Abstract available


  68. TENSTAD HB, Nilsson AC, Dellgren CD, Lindegaard HM, et al
    Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR/EULAR 2010 classification criteria for rheumatoid arthritis.
    Scand J Rheumatol. 2019 Jul 2:1-3. doi: 10.1080/03009742.2019.1609079.
    PubMed     Abstract available


  69. HARTMAN L, Bos R, Buttgereit F, Guler-Yuksel M, et al
    Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial.
    Scand J Rheumatol. 2019;48:340-341.
    PubMed    


  70. WEITOFT T, Oberg K
    Dosing of intra-articular triamcinolone hexacetonide for knee synovitis in chronic polyarthritis: a randomized controlled study.
    Scand J Rheumatol. 2019;48:279-283.
    PubMed     Abstract available


  71. MARS NJ, Kerola AM, Kauppi MJ, Pirinen M, et al
    Patients with rheumatic diseases share similar patterns of healthcare resource utilization.
    Scand J Rheumatol. 2019;48:300-307.
    PubMed     Abstract available


    June 2019
  72. HAMBARDZUMYAN K, Hermanrud C, Marits P, Vivar N, et al
    Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population.
    Scand J Rheumatol. 2019 Jun 27:1-5. doi: 10.1080/03009742.2019.1602670.
    PubMed     Abstract available


  73. SHIMAGAMI H, Katada Y
    Successful treatment with tocilizumab for massive ascites due to secondary amyloidosis complicating rheumatoid arthritis: a case report.
    Scand J Rheumatol. 2019 Jun 27:1-2. doi: 10.1080/03009742.2019.1603325.
    PubMed    


  74. VERHOEF LM, Bos D, van den Ende C, van den Hoogen F, et al
    Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study.
    Scand J Rheumatol. 2019 Jun 21:1-9. doi: 10.1080/03009742.2019.1613674.
    PubMed     Abstract available


  75. HESLINGA M, Van Den Oever I, Jonker DL, Griep EN, et al
    Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme.
    Scand J Rheumatol. 2019 Jun 18:1-8. doi: 10.1080/03009742.2019.1600718.
    PubMed     Abstract available


  76. SUN H, Wang Y, Yao H, Wang L, et al
    The clinical significance of serum sCD25 as a sensitive disease activity marker for rheumatoid arthritis.
    Scand J Rheumatol. 2019 Jun 4:1-5. doi: 10.1080/03009742.2019.1574890.
    PubMed     Abstract available


    May 2019
  77. BLOMJOUS BS, Boers M, Den Uyl D, Twisk J, et al
    Predictors of sick leave and improved worker productivity after 52 weeks of intensive treatment in patients with early rheumatoid arthritis.
    Scand J Rheumatol. 2019 May 28:1-8. doi: 10.1080/03009742.2019.1570549.
    PubMed     Abstract available


  78. KOH JH, Lee J, Chung SH, Kwok SK, et al
    Phenotypic features and predictors of the clinical severity of keratoconjunctivitis sicca and salivary gland dysfunction in patients with Sjogren's syndrome: a longitudinal analysis of the Korean Initiative of primary Sjogren's Syndrome (KISS) cohort.
    Scand J Rheumatol. 2019;48:198-206.
    PubMed     Abstract available


  79. SECHER AE, Glintborg B, Gudbergsen H, Krogh NS, et al
    Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients.
    Scand J Rheumatol. 2019;48:178-184.
    PubMed     Abstract available


  80. WALLIS D, Holmes C, Holroyd C, Sonpal K, et al
    Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?
    Scand J Rheumatol. 2019;48:251-252.
    PubMed    


  81. CHRISTIANSEN AA, Hendricks RC, Primdahl J, Roessler KK, et al
    'Isn't biological treatment something healthy?' Lay people's perceptions of medical terms.
    Scand J Rheumatol. 2019;48:253-255.
    PubMed    


  82. VASAITIS L, Nordmark G, Theander E, Backlin C, et al
    Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjogren's syndrome.
    Scand J Rheumatol. 2019;48:207-212.
    PubMed     Abstract available


    April 2019
  83. MELLBLOM BENGTSSON M, Hagel S, Jacobsson L, Turesson C, et al
    Lower extremity function in patients with early rheumatoid arthritis during the first five years, and relation to other disease parameters.
    Scand J Rheumatol. 2019 Apr 29:1-8. doi: 10.1080/03009742.2019.1579859.
    PubMed     Abstract available


  84. L' AMI MJ, Ruwaard J, Krieckaert C, Nurmohamed MT, et al
    Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis.
    Scand J Rheumatol. 2019 Apr 23:1-5. doi: 10.1080/03009742.2019.1577915.
    PubMed     Abstract available


    March 2019
  85. WATANABE T, Takahashi Y, Hirabayashi K, Tomaru U, et al
    Acute fulminant myocarditis in a patient with primary Sjogren's syndrome.
    Scand J Rheumatol. 2019;48:164-165.
    PubMed    


  86. NILSSON AM, Tufvesson E, Hesselstrand R, Olsson P, et al
    Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjogren's syndrome patients.
    Scand J Rheumatol. 2019;48:149-156.
    PubMed     Abstract available


  87. MOLANO-GONZALEZ N, Olivares-Martinez E, Anaya JM, Hernandez-Molina G, et al
    Anti-citrullinated protein antibodies and arthritis in Sjogren's syndrome: a systematic review and meta-analysis.
    Scand J Rheumatol. 2019;48:157-163.
    PubMed     Abstract available


    November 2018
  88. VALLI A, Ranta N, Gronholm A, Silvennoinen O, et al
    Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis.
    Scand J Rheumatol. 2018 Nov 26:1-5. doi: 10.1080/03009742.2018.1520294.
    PubMed     Abstract available


  89. CHENG T, Wang M, Chen L, Guo Y, et al
    Increased expression of CD40/TRAF1 and activation of nuclear factor-kappakappaB-dependent proinflammatory gene expression in collagen-induced arthritis.
    Scand J Rheumatol. 2018;47:455-460.
    PubMed     Abstract available


  90. PIEL-JULIAN ML, Moulis G, Fournier P, Dupont R, et al
    Early use of anakinra in adult-onset Still's disease myocarditis.
    Scand J Rheumatol. 2018;47:511-512.
    PubMed    


    September 2018
  91. MATSUO T, Hashimoto M, Ito I, Kubo T, et al
    Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.
    Scand J Rheumatol. 2018 Sep 30:1-8. doi: 10.1080/03009742.2018.1477989.
    PubMed     Abstract available


  92. CHATZIDIONYSIOU K, Lukina G, Gabay C, Hetland ML, et al
    Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration.
    Scand J Rheumatol. 2018 Sep 27:1-7. doi: 10.1080/03009742.2018.1466363.
    PubMed     Abstract available


    August 2018
  93. HETLAND ML, Ostergaard M, Stengaard-Pedersen K, Junker P, et al
    Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
    Scand J Rheumatol. 2018 Aug 13:1-8. doi: 10.1080/03009742.2018.1466362.
    PubMed     Abstract available


    July 2018
  94. BARTELS LE, Pedersen AB, Kristensen NR, Jepsen P, et al
    Helicobacter pylori infection is not associated with rheumatoid arthritis.
    Scand J Rheumatol. 2018 Jul 17:1-8. doi: 10.1080/03009742.2018.1464205.
    PubMed     Abstract available


  95. BRAHE CH, Ostergaard M, Johansen JS, Defranoux N, et al
    Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Scand J Rheumatol. 2018 Jul 9:1-8. doi: 10.1080/03009742.2018.1464206.
    PubMed     Abstract available


  96. BILBERG A, Bremell T, Bjersing J, Mannerkorpi K, et al
    High prevalence of widespread pain in women with early rheumatoid arthritis.
    Scand J Rheumatol. 2018 Jul 5:1-8. doi: 10.1080/03009742.2018.1447683.
    PubMed     Abstract available


  97. KIM JW, Lee H, Park SH, Kim SK, et al
    Salivary gland ultrasonography findings are associated with clinical, histological, and serologic features of Sjogren's syndrome.
    Scand J Rheumatol. 2018;47:303-310.
    PubMed     Abstract available


  98. WANG CR, Chiu YC, Chen YC
    Successful treatment of refractory neutropenia in Felty's syndrome with rituximab.
    Scand J Rheumatol. 2018;47:340-341.
    PubMed    


    May 2018
  99. YOKOE I, Kobayashi H, Kobayashi Y, Giles JT, et al
    Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
    Scand J Rheumatol. 2018 May 28:1-7. doi: 10.1080/03009742.2017.1418424.
    PubMed     Abstract available


  100. SAGELOLI F, Quesada JL, Fautrel B, Salliot C, et al
    Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Etude et Suivi des Polyarthrites Indifferenciees Recentes).
    Scand J Rheumatol. 2018 May 18:1-7. doi: 10.1080/03009742.2018.1437216.
    PubMed     Abstract available


  101. PEDERSEN JK, Holst R, Primdahl J, Svendsen AJ, et al
    Mortality and its predictors in patients with rheumatoid arthritis: a Danish population-based inception cohort study.
    Scand J Rheumatol. 2018 May 9:1-7. doi: 10.1080/03009742.2017.1420223.
    PubMed     Abstract available


    April 2018
  102. SILJEHULT F, Arlestig L, Eriksson C, Rantapaa-Dahlqvist S, et al
    Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2018 Apr 27:1-6. doi: 10.1080/03009742.2018.1433232.
    PubMed     Abstract available


  103. TORRENTE-SEGARRA V, Bergstra SA, Salomon-Escoto K, Da Silva J, et al
    Is current smoking status and its relationship to anti-cyclic citrullinated peptide antibodies a predictor of worse response to biological therapies in rheumatoid arthritis patients?
    Scand J Rheumatol. 2018 Apr 23:1-4. doi: 10.1080/03009742.2017.1418423.
    PubMed     Abstract available


  104. HUSBERG M, Bernfort L, Hallert E
    Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-up.
    Scand J Rheumatol. 2018 Apr 3:1-6. doi: 10.1080/03009742.2017.1420224.
    PubMed     Abstract available


    March 2018
  105. FEDELE AL, Petricca L, Tolusso B, Alivernini S, et al
    Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.
    Scand J Rheumatol. 2018 Mar 15:1-9. doi: 10.1080/03009742.2017.1416668.
    PubMed     Abstract available


  106. ALANI H, Henty JR, Thompson NL, Jury E, et al
    Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjogren's syndrome (secondary Sjogren's syndrome) focusing on autoimmune rheumatic diseases.
    Scand J Rheumatol. 2018;47:141-154.
    PubMed     Abstract available


    February 2018
  107. DOKOUPILOVA E, Aelion J, Takeuchi T, Malavolta N, et al
    Secukinumab after anti-tumour necrosis factor-alpha therapy: a phase III study in active rheumatoid arthritis.
    Scand J Rheumatol. 2018 Feb 20:1-6. doi: 10.1080/03009742.2017.1390605.
    PubMed     Abstract available


  108. SCHARMGA A, Geusens P, Peters M, van den Bergh JP, et al
    Structural damage and inflammation on radiographs or magnetic resonance imaging are associated with cortical interruptions on high-resolution peripheral quantitative computed tomography: a study in finger joints of patients with rheumatoid arthritis a
    Scand J Rheumatol. 2018 Feb 20:1-9. doi: 10.1080/03009742.2018.1424234.
    PubMed     Abstract available


  109. NYSTAD TW, Fenstad AM, Furnes O, Fevang BT, et al
    Predictors for orthopaedic surgery in patients with rheumatoid arthritis: results from a retrospective cohort study of 1010 patients diagnosed from 1972 to 2009 and followed up until 2015.
    Scand J Rheumatol. 2018 Feb 15:1-9. doi: 10.1080/03009742.2017.1397188.
    PubMed     Abstract available


    January 2018
  110. BRAHE CH, Dehlendorff C, Ostergaard M, Johansen JS, et al
    Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and valida
    Scand J Rheumatol. 2018 Jan 16:1-11. doi: 10.1080/03009742.2017.1376107.
    PubMed     Abstract available


  111. BAECKLUND E, Backlin C, Ronnelid J, Toes R, et al
    Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2018 Jan 16:1-6. doi: 10.1080/03009742.2017.1376108.
    PubMed     Abstract available


  112. ZHENG N, Guo C, Wu R
    Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
    Scand J Rheumatol. 2018 Jan 10:1-3. doi: 10.1080/03009742.2017.1376109.
    PubMed    


  113. AURELL Y, Andersson M, Forslind K
    Cone-beam computed tomography, a new low-dose three-dimensional imaging technique for assessment of bone erosions in rheumatoid arthritis: reliability assessment and comparison with conventional radiography - a BARFOT study.
    Scand J Rheumatol. 2018 Jan 10:1-5. doi: 10.1080/03009742.2017.1381988.
    PubMed     Abstract available


  114. GRAM SB, Hess S, Ahlquist P, Hoilund-Carlsen PF, et al
    [(18)F]Sodium fluoride positron emission tomography/computed tomography: a predictor of early rheumatoid arthritis? A case report.
    Scand J Rheumatol. 2018 Jan 10:1-2. doi: 10.1080/03009742.2017.1369153.
    PubMed    


  115. EBSTEIN E, Ea HK
    Spontaneous resolution of Epstein-Barr virus-induced haemophagocytic lymphohistiocytosis in Still's disease treated by tocilizumab: a case report.
    Scand J Rheumatol. 2018;47:84-85.
    PubMed    


    October 2017
  116. KUIJPER TM, Luime JJ, Xiong H, de Jong P, et al
    Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study.
    Scand J Rheumatol. 2017 Oct 2:1-7. doi: 10.1080/03009742.2017.1349176.
    PubMed     Abstract available


    September 2017
  117. KOGA T, Kawashiri SY, Migita K, Sato S, et al
    Comparison of serum inflammatory cytokine concentrations in familial Mediterranean fever and rheumatoid arthritis patients.
    Scand J Rheumatol. 2017 Sep 2:1-3. doi: 10.1080/03009742.2017.1363281.
    PubMed    


  118. MANGNUS L, van Steenbergen HW, Reijnierse M, Kalvesten J, et al
    Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis.
    Scand J Rheumatol. 2017;46:364-368.
    PubMed     Abstract available


    August 2017
  119. KUETTEL D, Primdahl J, Christensen R, Ornbjerg LM, et al
    Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial.
    Scand J Rheumatol. 2017 Aug 25:1-8. doi: 10.1080/03009742.2017.1329457.
    PubMed     Abstract available


  120. RASMUSSEN SE, Pfeiffer-Jensen M, Drewes AM, Farmer AD, et al
    Vagal influences in rheumatoid arthritis.
    Scand J Rheumatol. 2017 Aug 2:1-11. doi: 10.1080/03009742.2017.1314001.
    PubMed     Abstract available


  121. GROSS J, Oubaya N, Eymard F, Hourdille A, et al
    Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case-control study.
    Scand J Rheumatol. 2017 Aug 2:1-2. doi: 10.1080/03009742.2017.1324910.
    PubMed    


  122. KIADALIRI AA, Kristensen LE, Englund M
    Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.
    Scand J Rheumatol. 2017 Aug 2:1-7. doi: 10.1080/03009742.2017.1314002.
    PubMed     Abstract available


    July 2017
  123. ROERDINK RL, Dietvorst M
    Prognostic factors associated with mortality in patients with arthritis: a descriptive cohort study - comments on the article by Andreasen et al.
    Scand J Rheumatol. 2017;46:331-332.
    PubMed    


    June 2017
  124. CUPPEN B, Fritsch-Stork R, Eekhout I, de Jager W, et al
    Proteomics to predict the response to tumour necrosis factor-alpha inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score.
    Scand J Rheumatol. 2017 Jun 26:1-10. doi: 10.1080/03009742.2017.1309061.
    PubMed     Abstract available


    May 2017
  125. BERTHOLD E, Mansson B, Gullstrand B, Geborek P, et al
    Tumour necrosis factor-alpha/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.
    Scand J Rheumatol. 2017 May 9:1-5. doi: 10.1080/03009742.2017.1290822.
    PubMed     Abstract available


  126. OSTGARD RD, Glerup H, Jurik AG, Kragstrup TW, et al
    Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients.
    Scand J Rheumatol. 2017 May 9:1-5. doi: 10.1080/03009742.2017.1286382.
    PubMed     Abstract available


  127. KONO M, Yasuda S, Kono M, Atsumi T, et al
    Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.
    Scand J Rheumatol. 2017 May 8:1-3. doi: 10.1080/03009742.2017.1297482.
    PubMed    


  128. CHIU YM, Tang CH, Hung ST, Yang YW, et al
    A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study.
    Scand J Rheumatol. 2017;46:236-240.
    PubMed     Abstract available


  129. HINKKA H, Vaattanen S, Ala-Peijari S, Nummi T, et al
    Effects of cold mist shower on patients with inflammatory arthritis: a crossover controlled clinical trial.
    Scand J Rheumatol. 2017;46:206-209.
    PubMed     Abstract available


    April 2017
  130. RANNIO T, Asikainen J, Hannonen P, Yli-Kerttula T, et al
    Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
    Scand J Rheumatol. 2017 Apr 3:1-7. doi: 10.1080/03009742.2016.1266029.
    PubMed     Abstract available


    March 2017
  131. LESUIS N, Verhoef LM, Nieboer LM, Bruyn GA, et al
    Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.
    Scand J Rheumatol. 2017;46:152-155.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: